Cardiovascular risk are higher in those with end-stage kidney disease (ESKD). One of the key factors of cardiovascular disease (CVD) is chronic inflammation. It has been suggested that lipopolysaccharide connects systemic inflammation to CVD. For a study, researchers examined the relationship between cardiovascular events in ESKD and lipopolysaccharide-binding protein (LBP), a surrogate marker of lipopolysaccharide, … Continue reading Cardiovascular Events and Lipopolysaccharide-binding Protein Levels in Hemodialysis Patients